These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26667616)

  • 1. [Cirrhosis of the liver and HCV].
    Hejda V
    Vnitr Lek; 2015 Nov; 61 Suppl 4():4s13-23. PubMed ID: 26667616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-invasive diagnostic methods of fibrosis in chronic hepatitis C virus infection: their role in treatment indication, follow-up and assessment of prognosis].
    Pár A; Vincze Á; Pár G
    Orv Hetil; 2015 May; 156(21):855-61. PubMed ID: 26038993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.
    Kim JH; Kim MN; Han KH; Kim SU
    Liver Int; 2015 Apr; 35(4):1103-15. PubMed ID: 24976523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C.
    Ogawa E; Furusyo N; Shimizu M; Ihara T; Hayashi T; Harada Y; Toyoda K; Murata M; Hayashi J
    Antivir Ther; 2015; 20(2):185-92. PubMed ID: 24941012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of etiological treatment on prognosis.
    Su CW; Yang YY; Lin HC
    Hepatol Int; 2018 Feb; 12(Suppl 1):56-67. PubMed ID: 28702738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort study: Apparent redundancy of fibrosis assessment in young persons with HCV; development of realistic approaches to break the paradigm.
    Paul Noel B; Peter C; Emma R; Asthika A; Francis DJ
    Ann Hepatol; 2022; 27(1):100550. PubMed ID: 34606981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy.
    Moustafa EF; Makhlouf N; Hassany SM; Helmy A; Nasr A; Othman M; Seif H; Darwish M; Hassan H; Hessen M
    Arab J Gastroenterol; 2017 Mar; 18(1):6-12. PubMed ID: 28262531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.
    Bachofner JA; Valli PV; Kröger A; Bergamin I; Künzler P; Baserga A; Braun D; Seifert B; Moncsek A; Fehr J; Semela D; Magenta L; Müllhaupt B; Terziroli Beretta-Piccoli B; Mertens JC
    Liver Int; 2017 Mar; 37(3):369-376. PubMed ID: 27678216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?
    D'Ambrosio R; Colombo M
    Liver Int; 2016 Jun; 36(6):783-90. PubMed ID: 26936383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.
    Zarski JP; Sturm N; Desmorat H; Melin P; Raabe JJ; Bonny C; Sogni P; Pinta A; Rouanet S; Babany G; Cheveau A; Chevallier M
    Liver Int; 2010 Aug; 30(7):1049-58. PubMed ID: 20492512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapy.
    Puente Á; Cabezas J; López Arias MJ; Fortea JI; Arias MT; Estébanez Á; Casafont F; Fábrega E; Crespo J
    Rev Esp Enferm Dig; 2017 Jan; 109(1):17-25. PubMed ID: 27990835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K; VAN Erpecum KJ; DE Knegt RJ
    J Thromb Haemost; 2007 Jan; 5(1):25-30. PubMed ID: 17239163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy.
    Knop V; Hoppe D; Welzel T; Vermehren J; Herrmann E; Vermehren A; Friedrich-Rust M; Sarrazin C; Zeuzem S; Welker MW
    J Viral Hepat; 2016 Dec; 23(12):994-1002. PubMed ID: 27500382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
    Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Fibrosis in the Post-HCV Era.
    Pinzani M
    Semin Liver Dis; 2015 May; 35(2):157-65. PubMed ID: 25974901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of antiviral therapy on the course of chronic HCV infection. A systematic review.
    Almasio PL; Venezia G; Craxì A
    Panminerva Med; 2003 Sep; 45(3):175-82. PubMed ID: 14618115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
    Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
    Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of liver disease severity in patients with chronic viral hepatitis].
    Grgurević I; Hrstić I; Vucelić B
    Acta Med Croatica; 2013 Oct; 67(4):291-301. PubMed ID: 24984328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection.
    Casado JL; Quereda C; Moreno A; Pérez-Elías MJ; Martí-Belda P; Moreno S
    J Viral Hepat; 2013 Dec; 20(12):829-37. PubMed ID: 24304452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.